Eli Lilly and Co (LLY)
783.17
-10.97
(-1.38%)
USD |
NYSE |
Dec 27, 16:00
782.99
-0.18
(-0.02%)
After-Hours: 20:00
Eli Lilly SG&A Expense (Quarterly): 2.100B for Sept. 30, 2024
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Amgen Inc | 1.625B |
| Regeneron Pharmaceuticals Inc | 714.40M |
| Vertex Pharmaceuticals Inc | 371.80M |
| Viking Therapeutics Inc | 13.77M |
| Moderna Inc | 281.00M |